Dr Yu Ye
Wellcome Trust
United Kingdom
Resolving ubiquitin-dependent degradation of misfolded proteins using advanced single-molecule techniques.
Wellcome Trust
338,950
01/06/14
4.0
Parkinson's disease & PD-related disorders
alzheimer | Neurodegen
My proposed research seeks to understand the links between degradation of protein aggregates and the ubiquitin-proteasome pathway. The project entails three goals. The first goal involves establishing a fluorescence-based system to detect individual interactions between aggregates and proteasomes. To achieve this, I will initially receive training on proteasome purification and examine how to modify proteins with specific ubiquitin chains. Subsequently, I will explore different fluorescence labe lling systems and optimise a labelling strategy for protein aggregates and the proteasome without disrupting their integrity. The fluorophores selected should be bright and photostable to be compatible with the single-molecule instruments. This single-molecule fluorescence system will be used to establish a method that can reveal interactions between individual protein aggregates and a single proteasome to determine the efficiency of degradation for different types of aggregates. The second goal will focus on aggregate degradation in cells using three-dimensional superresolution imaging. Heterogeneous interaction between aggregates and proteasomes can be resolved to determine whether certain types of aggregates can inhibit the proteasome. Finally, I will focus on cell lines with mutations on key Parkinson’s disease-related genes, and establish whether aggregate degradation is affected. Identifying altered degradation in these cells will relate proteasome functions directly to disease s tates.